Skip to main content
. 2021 Jul 6;12(14):1377–1387. doi: 10.18632/oncotarget.28000

Table 1. Cell viability evaluation after 48-hour treatments.

Cell Viability %
NT 91, 25 ± 5, 9
ELT 83, 10 ± 1, 7
DFX 90, 45 ± 8, 5
CYT 54, 40 ± 1, 2*
ELT + DFX 74, 40 ± 4, 1*
ELT + CYT* 44, 90 ± 6, 9*
DFX + CYT* 60, 30 ± 2, 5*

The table shows the percentage of cell viability after 48-hour treatment with ELT, DFX and Cytarabine, alone and in combination. The experiment was run in triplicate and results showed as mean ± SD. Student’s t test was used for statistical analysis. p ≤ 0.05 was considered statistically significant, * vs non-treated sample.

* p ≤ 0,05.